Interview with the Innovators

Ali McBride, PharmD, MS, BCPS

Clinical Coordinator
The University of Arizona Cancer Center
Tucson, AZ
Authored Items
An Expert Perspective on the Current and Future of Maintenance Therapy in Ovarian Cancer
Amina Ahmed, MD, Paula Anastasia, RN, MN, AOCN, Ali McBride, PharmD, MS, BCPS
Videos in Interview with the Innovators, Video, Ovarian Cancer
Immunotherapy in Combination with PARP Inhibitors as First-Line Maintenance Therapy in Ovarian Cancer
Amina Ahmed, MD, Paula Anastasia, RN, MN, AOCN, Ali McBride, PharmD, MS, BCPS
Videos in Interview with the Innovators, Video
Adverse Events and Improvements in Quality of Life Associated with First-Line Maintenance Therapy in Ovarian Cancer
Paula Anastasia, RN, MN, AOCN, Ali McBride, PharmD, MS, BCPS
Videos in Interview with the Innovators, Video
Management of Adverse Events Associated with PARP Inhibitors as First-Line Maintenance Therapy in Ovarian Cancer
Ali McBride, PharmD, MS, BCPS, Paula Anastasia, RN, MN, AOCN
Videos in Interview with the Innovators, Video
Combination Therapy as Maintenance in Ovarian Cancer
Amina Ahmed, MD, Ali McBride, PharmD, MS, BCPS, Paula Anastasia, RN, MN, AOCN
Videos in Interview with the Innovators, Video
Clinical Data on First-Line Maintenance Therapy in Ovarian Cancer
Amina Ahmed, MD, Ali McBride, PharmD, MS, BCPS, Paula Anastasia, RN, MN, AOCN
Videos in Interview with the Innovators, Video
Choosing Among PARP Inhibitors as Maintenance Therapy in Ovarian Cancer
Amina Ahmed, MD, Ali McBride, PharmD, MS, BCPS, Paula Anastasia, RN, MN, AOCN
Videos in Interview with the Innovators, Video
Choosing Maintenance Therapy in Ovarian Cancer
Amina Ahmed, MD, Ali McBride, PharmD, MS, BCPS, Paula Anastasia, RN, MN, AOCN
Videos in Interview with the Innovators, Video
A Review of Clinical Trials Suggesting the Use of PARP Inhibitors as First-Line Maintenance Therapy in Ovarian Cancer
Amina Ahmed, MD, Ali McBride, PharmD, MS, BCPS, Paula Anastasia, RN, MN, AOCN
Videos in Interview with the Innovators, Video
The Impact of Germline or Somatic HRD Testing on Treatment Decisions in Ovarian Cancer
Ali McBride, PharmD, MS, BCPS, Paula Anastasia, RN, MN, AOCN
Videos in Interview with the Innovators, Video
The Role of Genetic Testing in Patients with Ovarian Cancer
Amina Ahmed, MD, Paula Anastasia, RN, MN, AOCN, Ali McBride, PharmD, MS, BCPS
Videos in Interview with the Innovators, Video
New Multiple Myeloma Therapies on the Market
Ali McBride, PharmD, MS, BCPS
Conference Correspondent  in Conference Correspondent, ASH
Getting to Adherence‑Based Monitoring
Ali McBride, PharmD, MS, BCPS
Conference Correspondent  in Conference Correspondent, ASH
Helping to Relieve Patients' Financial Burden
Ali McBride, PharmD, MS, BCPS
Conference Correspondent  in Conference Correspondent, ASH
Patient Access to Oral Oncolytics
Ali McBride, PharmD, MS, BCPS
Conference Correspondent  in Conference Correspondent, ASH
Getting New Therapies to Patients
Ali McBride, PharmD, MS, BCPS
Conference Correspondent  in Conference Correspondent, ASH
Existing Oral and IV Therapies
Ali McBride, PharmD, MS, BCPS
Conference Correspondent  in Conference Correspondent, ASH
Tuesday, December 15, 2015 Presented by Ali McBride
Ali McBride, PharmD, MS, BCPS
Takeda Pharmacy Webinar 2015
Managing Patients on Oral Oncolytics
Ali McBride, PharmD, MS, BCPS
Conference Correspondent  in Conference Correspondent, ASH
Infusion-related Reactions
Ali McBride, PharmD, MS, BCPS, Nolan Ngo, PharmD, BCPS, Christopher Campen, PharmD, BCPS
TOP - May 2010 Vol 3, No 3
Last modified: March 2, 2017